Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro derived from the immunomodulatory peptide tuftsin, with added stabilisation residues. Originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has been the subject of significant preclinical and early clinical research into anxiolytic and nootropic mechanisms. BPeptide supplies Selank at ≥99% purity for reproducible laboratory research.
Anxiolytic Pathway Research
Selank is studied for its modulation of the GABAergic system, including positive allosteric effects on GABA-A receptors, a key target in anxiety related research.
Cellular Renewal Pathways
Researched for downstream growth hormone effects on cellular regeneration markers and systemic tissue repair processes.
BDNF Expression
Research models indicate Selank elevates brain derived neurotrophic factor (BDNF) expression, a key marker in neuroplasticity and cognitive function studies.
Immune Modulation
As an analogue of tuftsin, Selank retains immunomodulatory research interest, with observed effects on cytokine IL-6 expression in cell based assays.



Reviews
There are no reviews yet.